---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021629"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:03:52.845921+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Syra Health posts first profitable quarter in Q1 2026; net income $241K, EPS $0.02, revenue up 22%

## Summary
- Net income of $241,000 vs net loss of $(472,265) in Q1 2025; EPS $0.02 vs ($0.04).
- Total revenue $2.3M (+22% YoY); population health solutions grew 46% to $1.8M.
- Gross margin expanded to 42.7%, up 11 ppt from 31.7%.
- Cash on hand $2.9M; no long-term debt as of March 31, 2026.
- Adjusted EBITDA improved to $244,495 from $(462,239) in prior year.

## SEC filing metadata
- accession: 0001493152-26-021629
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/0001493152-26-021629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021629
- JSON: https://secwatch.observer/filing/0001493152-26-021629.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021629.txt

## Key facts
- Earnings Releases
  Syra Health Corp reported first quarter ended March 31, 2026 results: revenue $2.3 million, net income $240,979, EPS $0.02 per share.
  - Period: first quarter ended March 31, 2026
  - Revenue: $2.3 million
  - Net income: $240,979
  - EPS: $0.02 per share
  - Result: reported results
  source text: period ● Q1 2026 EPS grew to $0.02 per share versus ($0.04) in Q1 2025 ● Gross Margin rose to 42.7%, up 11 percentage points year-over-year ● Total revenue increased to $2.3 million, up 22% when compared to the prior year period Carmel, Ind., May 7, 2026 / PRNewswire – Syra Health Corp. (OTCQB: SYRA) (“Syra Health” or the “Company”), an integrated healthcare
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/0001493152-26-021629-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.